<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biopsychosoc Med</journal-id><journal-id journal-id-type="iso-abbrev">Biopsychosoc Med</journal-id><journal-title-group><journal-title>Biopsychosocial Medicine</journal-title></journal-title-group><issn pub-type="epub">1751-0759</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6357406</article-id><article-id pub-id-type="publisher-id">142</article-id><article-id pub-id-type="doi">10.1186/s13030-019-0142-7</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Current management strategies for the pain of elderly patients with burning mouth syndrome: a critical review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tu</surname><given-names>Trang T. H.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Takenoshita</surname><given-names>Miho</given-names></name><address><phone>+81358035898</phone><email>takenoshita.ompm@tmd.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Matsuoka</surname><given-names>Hirofumi</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Watanabe</surname><given-names>Takeshi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Suga</surname><given-names>Takayuki</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Aota</surname><given-names>Yuma</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Abiko</surname><given-names>Yoshihiro</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Toyofuku</surname><given-names>Akira</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 1014 9130</institution-id><institution-id institution-id-type="GRID">grid.265073.5</institution-id><institution>Department of Psychosomatic Dentistry, Graduate School of Medical and Dental sciences, </institution><institution>Tokyo Medical and Dental University, </institution></institution-wrap>1-5-45 Yushima, Bunkyo, Tokyo, 113-8549 Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1769 5590</institution-id><institution-id institution-id-type="GRID">grid.412021.4</institution-id><institution>Division of Disease Control and Molecular Epidemiology, Department of Oral Growth and Development, School of Dentistry, </institution><institution>Health Sciences University of Hokkaido, </institution></institution-wrap>Hokkaido, Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1769 5590</institution-id><institution-id institution-id-type="GRID">grid.412021.4</institution-id><institution>Division of Oral Medicine and Pathology, Department of Human Biology and Pathophysiology, School of Dentistry, </institution><institution>Health Sciences University of Hokkaido, </institution></institution-wrap>Hokkaido, Japan </aff></contrib-group><pub-date pub-type="epub"><day>31</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>13</volume><elocation-id>1</elocation-id><history><date date-type="received"><day>5</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>23</day><month>1</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Burning Mouth Syndrome (BMS), a chronic intraoral burning sensation or dysesthesia without clinically evident causes, is one of the most common medically unexplained oral symptoms/syndromes. Even though the clinical features of BMS have been astonishingly common and consistent throughout the world for hundreds of years, BMS remains an enigma and has evolved to more intractable condition. In fact, there is a large and growing number of elderly BMS patients for whom the disease is accompanied by systemic diseases, in addition to aging physical change, which makes the diagnosis and treatment of BMS more difficult. Because the biggest barrier preventing us from finding the core pathophysiology and best therapy for BMS seems to be its heterogeneity, this syndrome remains challenging for clinicians. In this review, we discuss currently hopeful management strategies, including central neuromodulators (Tricyclic Antidepressants - TCAs, Serotonin, and Norepinephrine Reuptake Inhibitors - SNRIs, Selective Serotonin Reuptake Inhibitors - SSRIs, Clonazepam) and solutions for applying non-pharmacology approaches. Moreover, we also emphasize the important role of patient education and anxiety management to improve the patients&#x02019; quality of life. A combination of optimized medication with a short-term supportive psychotherapeutic approach might be a useful solution.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Burning mouth syndrome</kwd><kwd>Medically unexplained oral symptoms</kwd><kwd>Management strategies</kwd><kwd>Elderly</kwd><kwd>Neuromodulators</kwd><kwd>Oral facial pain</kwd><kwd>Psychotherapy</kwd></kwd-group><funding-group><award-group><funding-source><institution>KAKENHI</institution></funding-source><award-id>16K11881</award-id><principal-award-recipient><name><surname>Toyofuku</surname><given-names>Akira</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par15">Burning Mouth Syndrome (BMS), also called &#x0201c;stomatodynia&#x0201d; or &#x0201c;glossodynia&#x0201d;, is one of the most common medically unexplained oral symptoms/syndromes (MUOS) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Over centuries, a large number of BMS studies have been conducted about the pathophysiology [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>], but so far with limited knowledge because of its heterogeneity [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. Although the clinical features of BMS have been astonishingly common and consistent throughout the world for hundreds of years, an ultimate treatment strategy has not been established [<xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref>]. At the Department of Psychosomatic Dentistry, Dental Hospital, Tokyo Medical and Dental University (TMDU), Japan, we have around 250 new BMS patients every year and currently treat 4&#x02013;5000 outpatients. Among them, approximately 55% are over 65&#x02009;years old. Because the majority of elderly patients are accompanied by systemic diseases and contraindications of tricyclic antidepressant, the first line in management of BMS, the population aging poses challenges in patient management [<xref ref-type="bibr" rid="CR12">12</xref>]. (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) The actual situation makes the diagnosis and treatments of BMS more complex and difficult. A recent study in the United Kingdom shows the profound financial impact of persistent orofacial pain on patients&#x02019; lives, in which the &#x02018;hidden economical-social cost&#x02019; was calculated around 3000 GBP (Great Britain Pound) per year [<xref ref-type="bibr" rid="CR13">13</xref>]. It has attracted attention and controversy as to HOW we should manage this syndrome in the elderly[<xref ref-type="bibr" rid="CR14">14</xref>]. In this review, we discuss real-world, useful strategies for the management of patients with BMS, especially the elderly.<fig id="Fig1"><label>Fig. 1</label><caption><p>The proportion of elderly among first-visit Burning Mouth Syndrome patients over the past 10&#x02009;years (2008&#x02013;2017)</p></caption><graphic xlink:href="13030_2019_142_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec2"><title>Overview of burning mouth syndrome</title><sec id="Sec3"><title>Definition</title><p id="Par16">The International Association for the Study of Pain (IASP) presents BMS as &#x0201c;a chronic condition characterized by a burning sensation of the oral mucosa for which no cause can be found&#x0201d; [<xref ref-type="bibr" rid="CR1">1</xref>]. The International headache society (IHS) defines BMS as &#x0201c;an intraoral burning sensation or dysesthesia, recurring daily for more than 2 hours per day over more than 3 months, without clinically evident causative lesions&#x0201d; [<xref ref-type="bibr" rid="CR15">15</xref>]. This definition concretely shows the duration of daily and consecutive symptoms, thus it was preferred for use in diagnosis. The common finding among the definitions of BMS is the involvement of no obvious clinical causative lesions. However, the term BMS is sometimes used to describe an oral burning sensations that is induced by several local or systemic conditions, also called &#x0201c;secondary&#x0201d; BMS, instead of an &#x0201c;exact&#x0201d; oral pain/dysesthesia condition with unknown origin or &#x0201c;primary&#x0201d; BMS. This inconsistency indicates that although the diagnostic criteria for BMS have become more sophisticated they remain a little rough. They can include many causative factors and heterogeneous patients, because of the lack of accurate biomarkers and little knowledge of pathophysiology [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR16">16</xref>].</p></sec><sec id="Sec4"><title>Epidemiology</title><p id="Par17">There are several epidemiology studies that include &#x0201c;secondary&#x0201d; BMS while only a few are conducted on &#x0201c;exact&#x0201d; BMS. Overall, the prevalence of BMS in the adult population has been reported to be between 0.7 and 3.7% [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. The syndrome usually occurs in middle-aged and elderly patients more often than in children and adolescents, and female predominance has been reported (female: male&#x02009;=&#x02009;7:1) [<xref ref-type="bibr" rid="CR19">19</xref>]. The relevance of psychiatric disorders in BMS is remains to be clarified, but one study reported that about 50% of BMS patients have specific psychiatric diagnoses, 60% of whom are diagnosed with mood disorders [<xref ref-type="bibr" rid="CR20">20</xref>]. Overlap with other MUOS (atypical odontalgia, phantom bite syndrome, oral cenesthopathy) should be also carefully considered. BMS is sometimes comorbid with atypical odontalgia in the same patient, which contributes to a more intensively painful experience [<xref ref-type="bibr" rid="CR21">21</xref>].</p></sec><sec id="Sec5"><title>Pathophysiology</title><p id="Par18">BMS is a syndrome of unknown causes for which the etiology and pathological origin are under debate [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Patients often have been regarded as having psychogenic conditions [<xref ref-type="bibr" rid="CR22">22</xref>]. Although many attempts have been made to clarify the relation between BMS and psychological factors, the relation remains unclear [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par19">The majority of BMS patients are postmenopausal women, thus the association with female hormones has been proposed [<xref ref-type="bibr" rid="CR25">25</xref>]. Furthermore, a study reported that because BMS patients frequently suffer from taste disturbance and other similar problems, dysfunction of the chorda tympani nerve may be involved [<xref ref-type="bibr" rid="CR26">26</xref>]. Other researchers support the hypothesis that BMS may be a neuropathic pain involving the central nervous system [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. It is probably true that some central sensitization might be related to BMS, as are other functional somatic syndromes [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>], however, recent evidence shows its limitations, especially for elderly patients [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. In addition, the pathophysiology should be considered not only as a pure painful sensation but also as oral discomfort that includes dysgeusia and subjective dry mouth [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>], which seems to be more common in the elderly.</p><p id="Par20">In this review, we assume that the etiology and pathophysiology of BMS might not be that simple, but rather a complex, multifactorial condition. BMS symptoms seem to represent something of an amalgam of various factors in the same patient. (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) From a clinical viewpoint, the efficacy of some antidepressants [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref>] might be the best evidence showing the relation to dysregulation of some neurotransmitters, including dopamine nervous systems [<xref ref-type="bibr" rid="CR7">7</xref>], which probably affect complex neurological networks [<xref ref-type="bibr" rid="CR29">29</xref>]. In future study, neuroimaging will play a promising, key-role in clarifying the mechanisms of the central nervous system [<xref ref-type="bibr" rid="CR34">34</xref>&#x02013;<xref ref-type="bibr" rid="CR37">37</xref>].<fig id="Fig2"><label>Fig. 2</label><caption><p>Causative components of Burning Mouth Syndrome</p></caption><graphic xlink:href="13030_2019_142_Fig2_HTML" id="MO2"/></fig></p></sec></sec><sec id="Sec6"><title>Diagnosis based on clinical features</title><p id="Par21">The diagnosis of BMS remains challenging because it shares symptoms with several conditions, such as Candida infection, allergy, or nutritional deficiency. In real-life clinical situations, instead of using the classification-based criteria of ICHD or IASP clinicians usually do differential diagnosis to rule out other possible related conditions [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. To address how to do more precise BMS diagnosis, we suggest in this review that some classical clinical features be added to the official criteria proposed by ICHD and IASP. (Table <xref rid="Tab1" ref-type="table">1</xref>) These clinical features of BMS might be helpful for decreasing the time to diagnosis and improving accuracy.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristic symptoms of patients with Burning Mouth Syndrome</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>1</td><td>Pain may immigrate or spread independent of the anatomy of peripheral nerves<break/>(facial skin is not usually affected)</td></tr><tr><td>2</td><td>Spontaneous pain that worsens as the day progresses</td></tr><tr><td>3</td><td>No pain during eating, sleeping or concentrating on something</td></tr><tr><td>4</td><td>Symptom relief with candy or chewing gum</td></tr><tr><td>5</td><td>Symptom often follows or is associated with a history of medication, recent illness, or dental treatment</td></tr><tr><td>6</td><td>Regardless of the nature of onset, symptoms persist for many years</td></tr><tr><td>7</td><td>Fear of cancer/ cancerophobia</td></tr><tr><td>8</td><td>Sensitive to hot and/or spicy foods</td></tr><tr><td>9</td><td>Symptoms increased by talking or upon stress or fatigue</td></tr><tr><td>10</td><td>Little effect with NSAIDs, steroid ointments, gargling, tooth brushing etc.</td></tr><tr><td>11</td><td>Dysgeusia; loss of taste, taste disturbance, such as a bitter or metallic taste</td></tr><tr><td>12</td><td>Subjective dry mouth /increased thirst</td></tr><tr><td>13</td><td>Except burning/numbness, pain often accompanied by discomfort sensation (sore mouth, &#x0201c;rubbed with teeth&#x0201d;, &#x0201c;astringent persimmon juice&#x0201d;, &#x0201c;roughness&#x0201d;, &#x0201c;sticky&#x0201d;, e.g)</td></tr></tbody></table></table-wrap></p><p id="Par22">Our clinical routine usually starts with a review of the medical history, examining extra/intra oral findings, and checking the consistency of subjective symptoms. (Table <xref rid="Tab1" ref-type="table">1</xref>) Then, we perform a general medical examination, do blood tests and salivary measurement, do imaging such as MRI, and CT scan, and give psychological questionnaires [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. While taking care of elderly patients, who often have multiple systemic diseases and take numerous kinds of medications in addition to experiencing normal physical change from aging, clinicians should be aware of the possibility of underlying malignant tumors (Fig. <xref rid="Fig3" ref-type="fig">3</xref>) and dementia [<xref ref-type="bibr" rid="CR38">38</xref>]. After checking for the above, the final diagnose depends mainly on the patients&#x02019; subjective symptoms and history. Most of the complaints of BMS patients&#x02019; are focused on their tongue, usually a tingling/burning/numbing sensation or feeling [<xref ref-type="bibr" rid="CR27">27</xref>]. Symptoms related to the palate, lip, or gingiva are also observed, however, facial skin is not usually affected. Symptoms are often relieved by having a food like chewing gum or candy in the patient&#x02019;s mouth, and they worsen throughout the day [<xref ref-type="bibr" rid="CR3">3</xref>].<fig id="Fig3"><label>Fig. 3</label><caption><p>MR imaging a 70&#x02009;year old male complaining of burning tongue. He was found to have a carcinoma of the left submandibular gland</p></caption><graphic xlink:href="13030_2019_142_Fig3_HTML" id="MO3"/></fig></p><p id="Par23">There are several comorbid oral symptoms other than pain, such as dry mouth and taste disturbance [<xref ref-type="bibr" rid="CR6">6</xref>]. In addition, BMS has been linked with psychological factors, including stress, depression and anxiety [<xref ref-type="bibr" rid="CR39">39</xref>]. Cancerophobia, a type of anxiety disorder, was more frequently seen in patients with BMS than in those with other types of orofacial pain [<xref ref-type="bibr" rid="CR40">40</xref>]. This hints that the &#x0201c;pain&#x0201d; of BMS involves some qualities that evoke life-threatening emotion or restlessness in the patient. Like with other MUOS, BMS patients often do medical institution shopping, but usually are found to have no abnormal findings and thus experience strong frustration. Because of this shopping, delays in the diagnosis of BMS and referral to an appropriate medical institution were frequently reported [<xref ref-type="bibr" rid="CR41">41</xref>].</p></sec><sec id="Sec7"><title>A dilemma in the management of burning mouth syndrome</title><p id="Par24">The management of BMS had been said to be like a &#x02018;jumble of wheat and chaff,&#x02019; [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>] with little evidence to support or refute the various interventions [<xref ref-type="bibr" rid="CR44">44</xref>&#x02013;<xref ref-type="bibr" rid="CR46">46</xref>]. Moreover, there are &#x0201c;too many reviews and too few trials,&#x0201d; [<xref ref-type="bibr" rid="CR47">47</xref>] which results in difficulty in choosing the most appropriate approach to therapy for each patient with BMS.</p><p id="Par25">It would be accurate to say that there is no all-powerful treatment that can be effective for all BMS patients, in light of the various underlying conditions. The heterogeneity of this syndrome is the biggest barrier to reaching the best therapy. The nature of BMS is that it is a syndrome that has several causative factors, including some of psychosomatic nature such as chronic pain [<xref ref-type="bibr" rid="CR24">24</xref>]. Hence, the treatment response of patients differs depending on the predominant individual confounding pathological factors, such as neuropathic components, central sensitization, and psychiatric comorbidities. The problems are intertwined in such a complex way that treatment problems cannot be solved completely by a single therapy.</p><p id="Par26">In addition, no sufficiently effective assessment tool for BMS remission is available. As stated by Albert Einstein, &#x0201c;Not everything that can be counted counts and not everything that counts can be counted&#x0201d; [<xref ref-type="bibr" rid="CR48">48</xref>]. The suffering of BMS can hardly be explained in Visual Analogue Scale (VAS) scores. Nevertheless, BMS involves not only pure pain sensation but also dysesthesia, such as dryness or dysgeusia. Clinicians, therefore, should carefully consider what a patient claims to be &#x0201c;pain&#x0201d; [<xref ref-type="bibr" rid="CR29">29</xref>]. To conclude, we need more qualitative assessment methods that provide insight into the patients&#x02019; experience of pain instead of depending only on VAS [<xref ref-type="bibr" rid="CR49">49</xref>].</p><p id="Par27">Like other chronic pain, the treatment outcome of BMS can be explained by placebo effects [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. In contrast with clinical data such as blood pressure and cell blood counts, VAS does not give precise measurements. With no gold-standard instrument, clinicians struggle to find alternative biomarkers and proper assessment tools for the diagnosis of this long-lasting, complex syndrome.</p><p id="Par28">Another important problem is the assessment of duration and follow-up period [<xref ref-type="bibr" rid="CR52">52</xref>]. BMS has continuous, long-lasting symptoms that often fluctuate. There is no reliable data on longitudinal outcome or recurrence in existing RCTs for BMS. Considering the nature of BMS, treatment outcome should be assessed after a sufficient period of observation. Retrospective, long-term treatment outcome may be a more critical option. We should observe and analyze the existing data to compare the past and present treatment outcomes in order to improve the patients&#x02019; function and quality of life (QoL) [<xref ref-type="bibr" rid="CR53">53</xref>]. We suggest that real-world data may be more essential than short term RCTs to determine the benefits and limitations of a treatment regimen.</p></sec><sec id="Sec8"><title>Currently hopeful treatment strategies</title><p id="Par29">Even though there were many limitations mentioned above, we have high expectations for some treatments for BMS. The efficacy of central neuromodulators (Tricyclic Antidepressants - TCAs, Serotonin and Norepinephrine Reuptake Inhibitors - SNRIs, Selective Serotonin Reuptake Inhibitors - SSRIs, Clonazepam) and cognitive behavioral therapy (CBT) are supported by many studies [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>] and consistent with our clinical experience.</p><sec id="Sec9"><title>Central neuromodulators</title><p id="Par30">In the 1970s, amitriptyline, a TCA, was used for BMS as the first line medication in Japan [<xref ref-type="bibr" rid="CR53">53</xref>]. Response to TCA needed at least a few days and was not always certain, and side effects emerged quickly and often intensively. If the patients could feel slight improvement, even minor, they were willing to continue the medication and bear its side effects. However, unlike patients with classical trigeminal neuralgia, another type of persistent orofacial pain [<xref ref-type="bibr" rid="CR13">13</xref>], who usually respond very well to carbamazepine, not all BMS patients can be treated with TCAs. It is important to emphasize here that antidepressants are not always a &#x0201c;magical bullet&#x0201d; for BMS, however, symptom relief could be achieved with careful prescription. Recent research suggests that a change of salivation and QTc interval in cardiology might predict treatment response to amitriptyline [<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>].</p><p id="Par31">Other than TCAs, SNRIs and SSRIs have shown potential in the treatment of BMS [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR57">57</xref>&#x02013;<xref ref-type="bibr" rid="CR59">59</xref>]. However, they are not always sufficiently effective and some have characteristic side effects and drug interactions (withdrawal symptoms, a little different from TCA) and thus require special caution [<xref ref-type="bibr" rid="CR60">60</xref>]. In general, the cost-effectiveness of TCA is probably better than SSRIs and SNRIs. Nevertheless, they are useful if their benefits and risks are carefully considered, especially for the elderly [<xref ref-type="bibr" rid="CR61">61</xref>].</p><p id="Par32">These weak points have inhibited the wide use of neuromodulators. Careful dosing and observation are critical to obtaining the best efficacy with the least side effects. A recent report on functional gastrointestinal disorders and non- gastrointestinal painful disorders recommended using a low to modest dosage of neuromodulators and provide the most convincing evidence of benefit [<xref ref-type="bibr" rid="CR62">62</xref>], a finding similar to our clinical observation. Additionally, careful attention should be paid to cognitive impairment when long-term medication is provided to elderly patients. To cover these limitations, dopaminergic medications might be helpful in some cases [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. Nevertheless, they should not be prescribed easily [<xref ref-type="bibr" rid="CR65">65</xref>].</p><p id="Par33">In addition, Clonazepam - a kind of benzodiazepines (BZs) also used as an antiepileptic, might be a better option than TCAs [<xref ref-type="bibr" rid="CR66">66</xref>]. It is often used as the first-line medication without severe side effects, except drowsiness, and the patient often feels better shortly. However, its effect usually is temporary, gradually decreases, and contains the risk of dependency, like other BZs. An oral rinse of Clonazepam had high expectations [<xref ref-type="bibr" rid="CR67">67</xref>], however, in our clinical experience it seems to work successfully only at random. Also, for elderly patients the risk of falling and cognitive disturbances related to systemic BZ prescription must be seriously considered. For the same reason, gabapentinoids (Gabapentin and Pregabalin) should also be prescribed with caution [<xref ref-type="bibr" rid="CR68">68</xref>].</p></sec><sec id="Sec10"><title>Non-pharmacotherapeutic approaches</title><p id="Par34">CBT is one of the effective treatments for burning mouth syndrome. Previous research has shown that the pain severity and discomfort of BMS were improved by CBT targeting cognitive factors [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. Although the treatment effects were very large and were maintained for 6&#x02009;months to 12&#x02009;months, 12 to 16 sessions are necessary to complete a CBT course, which makes it difficult to do for BMS patients due to its high treatment cost.</p><p id="Par35">We recommend here three solutions for reducing the high cost of conducting CBT. The first is using a group format instead of an individual format. Previous research shows that CBT conducted as a form of group treatment and of short duration (1&#x02013;2 sessions) improved the pain and anxiety of BMS patients [<xref ref-type="bibr" rid="CR71">71</xref>]. Because no significant difference in effectiveness was shown in comparison with the individual format [<xref ref-type="bibr" rid="CR72">72</xref>], CBT delivered as group format would be an effective, low-cost alternative solution.</p><p id="Par36">The second solution for BMS patients is limiting the treatment content so that it focuses on specific characteristics. Recently, it was demonstrated that pain-related catastrophizing, a cognitive factor, influences pain severity and oral health-related QoL in BMS [<xref ref-type="bibr" rid="CR73">73</xref>]. Pain-related catastrophizing maintains and exacerbates chronic pain, thus focusing on pain-related catastrophizing is an important aspect of treatment. Treatment focused on the amelioration of pain-related catastrophizing significantly improved the symptoms of BMS patients [<xref ref-type="bibr" rid="CR74">74</xref>]. The treatment regimen used in this program consisted of four sessions, showing that CBT can be delivered with low cost by focusing on pain-related catastrophizing.</p><p id="Par37">The third solution is limiting the techniques using in the treatment. Although CBT usually consists of multiple techniques, including psycho-education about disease and treatment and cognitive and behavioral techniques, a treatment regimen containing only psycho-education was shown to be successful for BMS [<xref ref-type="bibr" rid="CR75">75</xref>]. In this psycho-education program, patients were provided various information about BMS, such as its characteristics, possible mechanisms, and treatment options including medications, which relieved the patients concern about the possible malignant nature of the condition. The importance of maintaining a normal lifestyle despite changes in their symptoms was emphasized. Delivering this extensive information was shown to improve BMS with low cost.</p><p id="Par38">Sleep disorder is another important issue because it is frequently comorbid with BMS, with a prevalence of over 60% [<xref ref-type="bibr" rid="CR76">76</xref>]. Sleep and chronic pain are bidirectional, thus pain can interfere with sleep and sleep disturbance can exacerbate pain [<xref ref-type="bibr" rid="CR77">77</xref>]. This high prevalence of sleep disorder might lead to worsening of the symptoms of BMS. CBT-I, an effective treatment for sleep disorder, improved the sleep disturbance and pain symptoms of chronic pain patients [<xref ref-type="bibr" rid="CR78">78</xref>]. Integrating CBT-I into the usual treatment for BMS would likely enhance the effectiveness of CBT for BMS patients.</p><p id="Par39">Another issue involving BMS is adherence to medication. Although psychotropic medications are effective in the treatment of BMS, a high frequency of non-adherence was found in a population study of psychotropic medications [<xref ref-type="bibr" rid="CR79">79</xref>]. In BMS, about 15% of the patients stop taking psychotropic medications [<xref ref-type="bibr" rid="CR80">80</xref>]. These non-adherent patients could be helped by motivational interviewing, which is a CBT technique that can be used to enhance medication adherence [<xref ref-type="bibr" rid="CR81">81</xref>].</p><p id="Par40">For patients who cannot use any drugs, repetitive transcranial magnetic stimulation (r TMS) may be effective [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. However, this approach needs an expensive, dedicated machine and requires much more time and effort in the clinic than do the usual pharmacotherapies. Another option is electro-convulsive therapy (ECT), which has shown beneficial results for severe and refractory cases with psychotic features, including a high risk of suicide [<xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR85">85</xref>]. Fortunately, few patients are unable to use all of the potential medications, and for the few who can&#x02019;t we recommend consultation with a psychiatrist.</p></sec><sec id="Sec11"><title>Patient education and anxiety management without special therapies</title><p id="Par41">Although CBT is a good option for the management of BMS management, specialist psychotherapists are not always available. Therefore, it is generally difficult to conduct orthodox therapy in the limited- space and time available in a real clinical situation [<xref ref-type="bibr" rid="CR74">74</xref>]. More importantly, the effect of psychotherapy greatly depends on the capacity of the psychotherapist. Psychotherapy is especially difficult with older patients who have lost their mind plasticity [<xref ref-type="bibr" rid="CR86">86</xref>].</p><p id="Par42">Clinicians should not feel pressure to diminish all the symptoms of all their patients with BMS or to finish treatment quickly. We not only need to &#x0201c;manage&#x0201d; the symptoms of BMS, but also the improvement of the patients&#x02019; QoL. In the general clinical setting, a combination of optimized medication with a short-term supportive psychotherapeutic approach would be a promising solution [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. Successful disease management cannot be achieved only by pharmacology, but also needs effective communication to build a positive patient-doctor relationship [<xref ref-type="bibr" rid="CR62">62</xref>].</p><p id="Par43">First, clinicians should be cognizant of patient anxiety, which is not always at a psychopathological level. Patients are often unsettled by chronic oral pain/discomfort of unknown origin [<xref ref-type="bibr" rid="CR41">41</xref>]. It is important to thoroughly rule out other medical conditions, especially malignancy. These ruling-out processes may relieve the patients&#x02019; anxieties and sometimes work as a kind of psychotherapy by themselves [<xref ref-type="bibr" rid="CR75">75</xref>]. Plain and easy to understand explanation and reassurance that there is no malignancy are necessary. An accurate diagnosis of BMS may also play an important role in relieving a patient&#x02019;s anxiety/fear of their symptoms. Finally, it can promote the effectiveness of pharmacotherapy of any kind.</p><p id="Par44">Second, it is not always necessary and sometimes impossible to attempt to perfectly diminish pain at once. In a real clinical situation, recovery to normal life should be the priority achievement. &#x0201c;Normal life&#x0201d; does not mean an ideal life without any worries, but can be achieved when a patient can do almost everything necessary to their daily life without being bothered by slight oral symptoms. Even when 99% pain reduction is obtained, some patients continue to be annoyed by the minor residual pain and limit their daily activities. The pain and discomfort of BMS are of such a nature that they evoke emotional distress [<xref ref-type="bibr" rid="CR21">21</xref>]. Clinicians must understand this characteristic nature of BMS suffering and explain and enhance the role of patients in the medication decision-making process [<xref ref-type="bibr" rid="CR87">87</xref>] and repeatedly confirm the recovery process. It is also useful for recovery to their normal life to encourage the patient to continue sleep management [<xref ref-type="bibr" rid="CR77">77</xref>] and adequate physical exercise, such as walking, according to their symptom reduction.</p><p id="Par45">Additionally, the goal of treatment should be shared with patients as well as their family; and a prospective treatment course for BMS should be explained at the first visit to increase motivation for therapy, which can improve the prognosis. However, this is not always successful because of the rather wavelike, up and down, course of some patients&#x02019; symptoms. For instance, for some chronic pain patients with co-occurring persistent fatigue, over-predicting the goals in CBT probably leads to poor response [<xref ref-type="bibr" rid="CR88">88</xref>]. Patients should be informed of the fact that BMS is an intractable pain condition, but that it is not hopeless to obtain complete remission in the future. It is important to choose an appropriate, feasible goal. Supportive understanding from the family is important for BMS patient to prevent discontinuation of treatment, especially so for the elderly. Like other chronic pain conditions, the management of BMS requires empathy, patience, and time from the clinicians, patients, and family.</p><p id="Par46">Antidepressants have been shown to sometimes improve the BMS symptoms dramatically, within the first 5 - 7&#x02009;days, after which the symptoms gradually improve for 1-2&#x02009;months according to the dose, but perfect remission is not always reached [<xref ref-type="bibr" rid="CR89">89</xref>]. After some improvement during early treatment, it is very disappointing and irritating for the patients to be confronted with the residual small waves of symptoms, which is no longer called &#x0201c;pain&#x0201d;. Dysgeusia, or subjective dry mouth, has a tendency to improve a little later than pain (burning sensation), so patients tend to complain more about dysesthesia than &#x0201c;pain&#x0201d; in the later period. (Fig. <xref rid="Fig4" ref-type="fig">4</xref>) According to our clinical experience, it usually takes minimum of 3&#x02013;6&#x02009;months for patients to get to a satisfactory condition and to stabilize. Thorough and careful tapering of the drugs may lead to a good ending of the pharmacotherapy.<fig id="Fig4"><label>Fig. 4</label><caption><p>Typical clinical course of a Burning Mouth Syndrome patient treated with Tricyclic Antidepressants</p></caption><graphic xlink:href="13030_2019_142_Fig4_HTML" id="MO4"/></fig></p><p id="Par47">Meaningful treatment goals should to be set on level of satisfaction patients will feel as they recover from pain that interferes with their lives and how to adjust to functional disabilities. The focus should not be on the scores of clinical measurements [<xref ref-type="bibr" rid="CR49">49</xref>]. We should thoroughly understand these real responses to antidepressants for BMS without expecting a &#x0201c;miracle&#x0201d; recovery [<xref ref-type="bibr" rid="CR89">89</xref>].</p><p id="Par48">It is natural for a patient to feel anxiety about an unstable pain condition of unknown origin [<xref ref-type="bibr" rid="CR39">39</xref>]. As above mentioned, adding a psychological component to the usual therapeutic regimen based on pharmacotherapy should be considered in the treatment of BMS. These processes are difficult to describe in the context of evidence-based medicine/dentistry.</p><p id="Par49">In summary, BMS remains an enigma and has evolved into a more intractable condition, especially in the elderly. The diagnosis and treatment of BMS remains challenging. There are many problems with the existing treatment data on BMS, and long-term comprehensive assessment and outcome analysis are much needed. It is essential to maintain a supportive attitude to the patients and their family, assuring them of a good prognosis in the near future. Continuing psychological support and the careful use of antidepressants may help with the recovery of the brain function of these patients.</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>BMS</term><def><p id="Par2">Burning Mouth Syndrome</p></def></def-item><def-item><term>BZs</term><def><p id="Par3">Benzodiazepines</p></def></def-item><def-item><term>CBT</term><def><p id="Par4">Cognitive behavioral therapy</p></def></def-item><def-item><term>ECT</term><def><p id="Par5">Electro-convulsive therapy</p></def></def-item><def-item><term>IASP</term><def><p id="Par6">International Association for the Study of Pain</p></def></def-item><def-item><term>IHS</term><def><p id="Par7">International headache society</p></def></def-item><def-item><term>MUOS</term><def><p id="Par8">medically unexplained oral symptoms</p></def></def-item><def-item><term>QoL</term><def><p id="Par9">Quality of life</p></def></def-item><def-item><term>SNRIs</term><def><p id="Par10">Serotonin and Norepinephrine Reuptake Inhibitors</p></def></def-item><def-item><term>SSRIs</term><def><p id="Par11">Selective Serotonin Reuptake Inhibitors</p></def></def-item><def-item><term>TCAs</term><def><p id="Par12">Tricyclic Antidepressants</p></def></def-item><def-item><term>TMS</term><def><p id="Par13">Transcranial magnetic stimulation</p></def></def-item><def-item><term>VAS</term><def><p id="Par14">Visual Analogue Scale</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>Not applicable.</p><sec id="FPar1"><title>Funding</title><p id="Par50">This study was supported in part by the Japan Society for the Promotion of Science (JSPS) KAKENHI (grant number 16&#x02009;K11881).</p></sec><sec id="FPar2" sec-type="data-availability"><title>Availability of data and materials</title><p id="Par51">Not applicable.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>TTHT, MH, YA, HM, AT had major roles in drafting and revising the manuscript. TS, YA, TW contributed to the interpretation of ideas, reviewing the structure, and additional supplements. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p>Not applicable.</p></sec><sec id="FPar4"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar5"><title>Competing interests</title><p>The authors report no conflicts of interest in this work.</p></sec><sec id="FPar6"><title>Publisher&#x02019;s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Merskey H, Bogduk N. Classification of Chronic Pain. 2nd ed. <italic>Seattle, WA: IASP Press</italic>;. Descriptions of chronic pain syndromes and definitions of pain terms;1994 p.74.</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyofuku</surname><given-names>A</given-names></name></person-group><article-title>Psychosomatic problems in dentistry</article-title><source>Biopsychosoc Med.</source><year>2016</year><volume>10</volume><fpage>14</fpage><?supplied-pmid 27134647?><pub-id pub-id-type="pmid">27134647</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grushka</surname><given-names>M</given-names></name><name><surname>Epstein</surname><given-names>JB</given-names></name><name><surname>Gorsky</surname><given-names>M</given-names></name></person-group><article-title>Burning mouth syndrome</article-title><source>Am Fam Physician</source><year>2002</year><volume>65</volume><issue>4</issue><fpage>615</fpage><lpage>620</lpage><?supplied-pmid 11871678?><pub-id pub-id-type="pmid">11871678</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forssell</surname><given-names>H</given-names></name><name><surname>J&#x000e4;&#x000e4;skel&#x000e4;inen</surname><given-names>S</given-names></name><name><surname>List</surname><given-names>T</given-names></name><name><surname>Svensson</surname><given-names>P</given-names></name><name><surname>Baad-Hansen</surname><given-names>L</given-names></name></person-group><article-title>An update on pathophysiological mechanisms related to idiopathic oro-facial pain conditions with implications for management</article-title><source>J Oral Rehabil</source><year>2015</year><volume>42</volume><issue>4</issue><fpage>300</fpage><lpage>322</lpage><?supplied-pmid 25483941?><pub-id pub-id-type="pmid">25483941</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steele</surname><given-names>JC</given-names></name></person-group><article-title>The practical evaluation and management of patients with symptoms of a sore burning mouth</article-title><source>Clin Dermatol</source><year>2016</year><volume>34</volume><issue>4</issue><fpage>449</fpage><lpage>457</lpage><?supplied-pmid 27343959?><pub-id pub-id-type="pmid">27343959</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patton</surname><given-names>LL</given-names></name><name><surname>Siegel</surname><given-names>MA</given-names></name><name><surname>Benoliel</surname><given-names>R</given-names></name><name><surname>de Laat</surname><given-names>A</given-names></name></person-group><article-title>Management of burning mouth syndrome: systematic review and management recommendations</article-title><source>Oral Surg Oral Med Oral Pathol Oral Radiol Endo</source><year>2007</year><volume>103</volume><issue>suppl.39</issue><fpage>S39.e1</fpage><lpage>S39.e13</lpage></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000e4;&#x000e4;skel&#x000e4;inen</surname><given-names>SK</given-names></name><name><surname>Woda</surname><given-names>A</given-names></name></person-group><article-title>Burning mouth syndrome</article-title><source>Cephalalgia</source><year>2017</year><volume>37</volume><issue>7</issue><fpage>627</fpage><lpage>647</lpage><?supplied-pmid 28569120?><pub-id pub-id-type="pmid">28569120</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">P&#x000e9;rier JM, Boucher Y. History of burning mouth syndrome (1800-1950): a review. Oral Dis. 2018. 10.1111/odi.12860.</mixed-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charleston</surname><given-names>L</given-names><suffix>4th</suffix></name></person-group><article-title>Burning mouth syndrome: a review of recent literature</article-title><source>Curr Pain Headache Rep</source><year>2013</year><volume>17</volume><issue>6</issue><fpage>336</fpage><?supplied-pmid 23645183?><pub-id pub-id-type="pmid">23645183</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurvits</surname><given-names>GE</given-names></name><name><surname>Tan</surname><given-names>A</given-names></name></person-group><article-title>Burning mouth syndrome</article-title><source>World J Gastroenterol</source><year>2013</year><volume>19</volume><issue>5</issue><fpage>665</fpage><lpage>672</lpage><?supplied-pmid 23429751?><pub-id pub-id-type="pmid">23429751</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moghadam-Kia</surname><given-names>S</given-names></name><name><surname>Fazel</surname><given-names>N</given-names></name></person-group><article-title>A diagnostic and therapeutic approach to primary burning mouth syndrome</article-title><source>Clin Dermatol</source><year>2017</year><volume>35</volume><issue>5</issue><fpage>453</fpage><lpage>460</lpage><?supplied-pmid 28916026?><pub-id pub-id-type="pmid">28916026</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Suga T, Watanabe T, Aota Y, Nagamine T, Toyofuku A. Burning mouth syndrome: the challenge of an aging population. Geriatr Gerontol Int 2018: Article in Press.</mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Breckons M, Shen J, Bunga J, Vale L, Study DJDEEP. Indirect and out-of-pocket costs of persistent orofacial pain. J Dent Res. 2018.</mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname><given-names>T</given-names></name><name><surname>McCullough</surname><given-names>M</given-names></name></person-group><article-title>Oral medicine and the ageing population</article-title><source>Aust Dent J</source><year>2015</year><volume>60</volume><issue>Suppl 1</issue><fpage>44</fpage><lpage>53</lpage><?supplied-pmid 25762041?><pub-id pub-id-type="pmid">25762041</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018,38(1):178.</mixed-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000e4;&#x000e4;skel&#x000e4;inen</surname><given-names>SK</given-names></name></person-group><article-title>Pathophysiology of primary burning mouth syndrome</article-title><source>Clin Neurophysiol</source><year>2012</year><volume>123</volume><issue>1</issue><fpage>71</fpage><lpage>77</lpage><?supplied-pmid 22030140?><pub-id pub-id-type="pmid">22030140</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohorst</surname><given-names>JJ</given-names></name><name><surname>Bruce</surname><given-names>AJ</given-names></name><name><surname>Torgerson</surname><given-names>RR</given-names></name><name><surname>Schenck</surname><given-names>LA</given-names></name><name><surname>Davis</surname><given-names>MD</given-names></name></person-group><article-title>The prevalence of burning mouth syndrome: a population-based study</article-title><source>Br J Dermatol</source><year>2015</year><volume>172</volume><issue>6</issue><fpage>1654</fpage><lpage>1656</lpage><?supplied-pmid 25495557?><pub-id pub-id-type="pmid">25495557</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergdahl</surname><given-names>M</given-names></name><name><surname>Bergdahl</surname><given-names>J</given-names></name></person-group><article-title>Burning mouth syndrome: prevalence and associated factors</article-title><source>J Oral Pathol Med.</source><year>1999</year><volume>28</volume><issue>8</issue><fpage>350</fpage><lpage>354</lpage><?supplied-pmid 10478959?><pub-id pub-id-type="pmid">10478959</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savage</surname><given-names>NW</given-names></name></person-group><article-title>Burning mouth syndrome: patient management</article-title><source>Aust Dent J</source><year>1996</year><volume>41</volume><issue>6</issue><fpage>363</fpage><lpage>366</lpage><?supplied-pmid 9008990?><pub-id pub-id-type="pmid">9008990</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takenoshita</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Psychiatric diagnoses in patients with burning mouth syndrome and atypical odontalgia referred from psychiatric to dental facilities</article-title><source>Neuropsychiatr Dis Treat</source><year>2010</year><volume>6</volume><fpage>699</fpage><lpage>705</lpage><?supplied-pmid 21127687?><pub-id pub-id-type="pmid">21127687</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tu</surname><given-names>TTH</given-names></name><name><surname>Miura</surname><given-names>A</given-names></name><name><surname>Shinohara</surname><given-names>Y</given-names></name><name><surname>Mikuzuki</surname><given-names>L</given-names></name><name><surname>Kawasaki</surname><given-names>K</given-names></name><name><surname>Sugawara</surname><given-names>S</given-names></name><name><surname>Suga</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Umezaki</surname><given-names>Y</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Motomura</surname><given-names>H</given-names></name><name><surname>Takenoshita</surname><given-names>M</given-names></name><name><surname>Toyofuku</surname><given-names>A</given-names></name></person-group><article-title>Evaluating burning mouth syndrome as a comorbidity of atypical Odontalgia: the impact on pain experiences</article-title><source>Pain Pract</source><year>2017</year><volume>18</volume><issue>5</issue><fpage>580</fpage><lpage>586</lpage><?supplied-pmid 28972293?><pub-id pub-id-type="pmid">28972293</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abetz</surname><given-names>LM</given-names></name><name><surname>Savage</surname><given-names>NW</given-names></name></person-group><article-title>Burning mouth syndrome and psychological disorders</article-title><source>Aust Dent J</source><year>2009</year><volume>54</volume><issue>2</issue><fpage>84</fpage><lpage>93</lpage><?supplied-pmid 19473148?><pub-id pub-id-type="pmid">19473148</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Souza</surname><given-names>FT</given-names></name><name><surname>Teixeira</surname><given-names>AL</given-names></name><name><surname>Amaral</surname><given-names>TM</given-names></name><name><surname>dos Santos</surname><given-names>TP</given-names></name><name><surname>Abreu</surname><given-names>MH</given-names></name><name><surname>Silva</surname><given-names>TA</given-names></name><name><surname>Kummer</surname><given-names>A</given-names></name></person-group><article-title>Psychiatric disorders in burning mouth syndrome</article-title><source>J Psychosom Res</source><year>2012</year><volume>72</volume><issue>2</issue><fpage>142</fpage><lpage>146</lpage><?supplied-pmid 22281456?><pub-id pub-id-type="pmid">22281456</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bushnell</surname><given-names>MC</given-names></name><name><surname>Ceko</surname><given-names>M</given-names></name><name><surname>Low</surname><given-names>LA</given-names></name></person-group><article-title>Cognitive and emotional control of pain and its disruption in chronic pain</article-title><source>Nat Rev Neurosci</source><year>2013</year><volume>14</volume><issue>7</issue><fpage>502</fpage><lpage>511</lpage><?supplied-pmid 23719569?><pub-id pub-id-type="pmid">23719569</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leimola-Virtanen</surname><given-names>R</given-names></name><etal/></person-group><article-title>Expression of estrogen receptor (ER) in oral mucosa and salivary glands</article-title><source>Maturitas</source><year>2000</year><volume>36</volume><fpage>131</fpage><lpage>137</lpage><?supplied-pmid 11006500?><pub-id pub-id-type="pmid">11006500</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grushka</surname><given-names>M</given-names></name><etal/></person-group><article-title>Taste dysfunction in burning mouth syndrome</article-title><source>Gerodontics</source><year>1988</year><volume>4</volume><fpage>256</fpage><lpage>258</lpage><?supplied-pmid 3271722?><pub-id pub-id-type="pmid">3271722</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000e4;&#x000e4;skel&#x000e4;inen</surname><given-names>SK</given-names></name></person-group><article-title>Clinical neurophysiology and quantitative sensory testing in the investigation of orofacial pain and sensory function</article-title><source>J Orofac Pain</source><year>2004</year><volume>18</volume><issue>2</issue><fpage>85</fpage><lpage>107</lpage><?supplied-pmid 15250429?><pub-id pub-id-type="pmid">15250429</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neblett</surname><given-names>R</given-names></name><name><surname>Cohen</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>Y</given-names></name><name><surname>Hartzell</surname><given-names>MM</given-names></name><name><surname>Williams</surname><given-names>M</given-names></name><name><surname>Mayer</surname><given-names>TG</given-names></name><name><surname>Gatchel</surname><given-names>RJ</given-names></name></person-group><article-title>The central sensitization inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample</article-title><source>J Pain</source><year>2013</year><volume>14</volume><issue>5</issue><fpage>438</fpage><lpage>445</lpage><?supplied-pmid 23490634?><pub-id pub-id-type="pmid">23490634</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolf</surname><given-names>CJ</given-names></name></person-group><article-title>What is this thing called pain?</article-title><source>J Clin Invest</source><year>2010</year><volume>120</volume><issue>11</issue><fpage>3742</fpage><lpage>3744</lpage><?supplied-pmid 21041955?><pub-id pub-id-type="pmid">21041955</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>J&#x000e4;&#x000e4;skel&#x000e4;inen</surname><given-names>SK</given-names></name></person-group><article-title>Is burning mouth syndrome a neuropathic pain condition?</article-title><source>Pain</source><year>2018</year><volume>159</volume><issue>3</issue><fpage>610</fpage><lpage>613</lpage><?supplied-pmid 29257770?><pub-id pub-id-type="pmid">29257770</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Honda M, Iida T, Kamiyama H, Masuda M, Kawara M, Svensson P, Komiyama O. Mechanical sensitivity and psychological factors in patients with burning mouth syndrome. Clin Oral Investig. 2018. 10.1007/s00784-018-2488-9.</mixed-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umezaki</surname><given-names>Y</given-names></name><name><surname>Miura</surname><given-names>A</given-names></name><name><surname>Shinohara</surname><given-names>Y</given-names></name><name><surname>Mikuzuki</surname><given-names>L</given-names></name><name><surname>Sugawara</surname><given-names>S</given-names></name><name><surname>Kawasaki</surname><given-names>K</given-names></name><name><surname>Toyofuku</surname><given-names>A</given-names></name></person-group><article-title>Clinical characteristics and course of oral somatic delusions: a retrospective chart review of 606 cases in 5 years</article-title><source>Neuropsychiatr Dis Treat</source><year>2018</year><volume>14</volume><fpage>2057</fpage><lpage>2065</lpage><?supplied-pmid 30147319?><pub-id pub-id-type="pmid">30147319</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umezaki</surname><given-names>Y</given-names></name><name><surname>Miura</surname><given-names>A</given-names></name><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Takenoshita</surname><given-names>M</given-names></name><name><surname>Uezato</surname><given-names>A</given-names></name><name><surname>Torihara</surname><given-names>A</given-names></name><name><surname>Nishikawa</surname><given-names>T</given-names></name><name><surname>Toyofuku</surname><given-names>A</given-names></name></person-group><article-title>Oral cenesthopathy</article-title><source>Biopsychosoc Med</source><year>2016</year><volume>10</volume><fpage>20</fpage><?supplied-pmid 27293481?><pub-id pub-id-type="pmid">27293481</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>SA</given-names></name><name><surname>Keaser</surname><given-names>ML</given-names></name><name><surname>Meiller</surname><given-names>TF</given-names></name><name><surname>Seminowicz</surname><given-names>DA</given-names></name></person-group><article-title>Altered structure and function in the hippocampus and medial prefrontal cortex in patients with burning mouth syndrome</article-title><source>Pain</source><year>2014</year><volume>155</volume><issue>8</issue><fpage>1472</fpage><lpage>1480</lpage><?supplied-pmid 24769366?><pub-id pub-id-type="pmid">24769366</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinozaki</surname><given-names>T</given-names></name><name><surname>Imamura</surname><given-names>Y</given-names></name><name><surname>Kohashi</surname><given-names>R</given-names></name><name><surname>Dezawa</surname><given-names>K</given-names></name><name><surname>Nakaya</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Morimoto</surname><given-names>Y</given-names></name><name><surname>Shizukuishi</surname><given-names>T</given-names></name><name><surname>Abe</surname><given-names>O</given-names></name><name><surname>Haji</surname><given-names>T</given-names></name><name><surname>Tabei</surname><given-names>K</given-names></name><name><surname>Taira</surname><given-names>M</given-names></name></person-group><article-title>Spatial and temporal brain responses to noxious heat thermal stimuli in burning mouth syndrome</article-title><source>J Dent Res</source><year>2016</year><volume>95</volume><issue>10</issue><fpage>1138</fpage><lpage>1146</lpage><?supplied-pmid 27302878?><pub-id pub-id-type="pmid">27302878</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshino</surname><given-names>A</given-names></name><name><surname>Okamoto</surname><given-names>Y</given-names></name><name><surname>Doi</surname><given-names>M</given-names></name><name><surname>Okada</surname><given-names>G</given-names></name><name><surname>Takamura</surname><given-names>M</given-names></name><name><surname>Ichikawa</surname><given-names>N</given-names></name><name><surname>Yamawaki</surname><given-names>S</given-names></name></person-group><article-title>Functional alterations of postcentral gyrus modulated by angry facial expressions during intraoral tactile stimuli in patients with burning mouth syndrome: a functional magnetic resonance imaging Study</article-title><source>Front Psychiatry</source><year>2017</year><volume>6</volume><issue>8</issue><fpage>224</fpage></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wada</surname><given-names>A</given-names></name><name><surname>Shizukuishi</surname><given-names>T</given-names></name><name><surname>Kikuta</surname><given-names>J</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Watanabe</surname><given-names>Y</given-names></name><name><surname>Imamura</surname><given-names>Y</given-names></name><name><surname>Shinozaki</surname><given-names>T</given-names></name><name><surname>Dezawa</surname><given-names>K</given-names></name><name><surname>Haradome</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>O</given-names></name></person-group><article-title>Altered structural connectivity of pain-related brain network in burning mouth syndrome-investigation by graph analysis of probabilistic tractography</article-title><source>Neuroradiology</source><year>2017</year><volume>59</volume><issue>5</issue><fpage>525</fpage><lpage>532</lpage><?supplied-pmid 28361345?><pub-id pub-id-type="pmid">28361345</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">Katagiri A, Sato Y, Umezaki Y, Sato T, Watanabe M, Takenoshita M, Yoshikawa T, Toyofuku A. Burning mouth Syndrome in an aged patient with Alzheimer's Disease : A case report. <italic>Jpn J Psychosom Dent.</italic> 2011;26(1):36&#x02013;40 (article in Japanese).</mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="other">Feller L, Fourie J, Bouckaert M, Khammissa RAG, Ballyram R, Lemmer J. Burning mouth syndrome: Aetiopathogenesis and principles of management. Pain Res Manag. 2017:1926269.</mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">Tait RC, Ferguson M, Herndon CM. Chronic orofacial pain: burning mouth syndrome and other neuropathic disorders. J Pain Manag Med 2017;3(1). pii:120.</mixed-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mignogna</surname><given-names>MD</given-names></name><name><surname>Fedele</surname><given-names>S</given-names></name><name><surname>Lo Russo</surname><given-names>L</given-names></name><name><surname>Leuci</surname><given-names>S</given-names></name><name><surname>Lo Muzio</surname><given-names>L</given-names></name></person-group><article-title>The diagnosis of burning mouth syndrome represents a challenge for clinicians</article-title><source>J Orofac Pain</source><year>2005</year><volume>19</volume><issue>2</issue><fpage>168</fpage><lpage>173</lpage><?supplied-pmid 15895840?><pub-id pub-id-type="pmid">15895840</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000e4;ggman-Henrikson</surname><given-names>B</given-names></name><name><surname>Alstergren</surname><given-names>P</given-names></name><name><surname>Davidson</surname><given-names>T</given-names></name><name><surname>H&#x000f6;gest&#x000e4;tt</surname><given-names>ED</given-names></name><name><surname>&#x000d6;stlund</surname><given-names>P</given-names></name><name><surname>Tranaeus</surname><given-names>S</given-names></name><name><surname>Vitols</surname><given-names>S</given-names></name><name><surname>List</surname><given-names>T</given-names></name></person-group><article-title>Pharmacological treatment of oro-facial pain - health technology assessment including a systematic review with network meta- analysis</article-title><source>J Oral Rehabil</source><year>2017</year><volume>44</volume><issue>10</issue><fpage>800</fpage><lpage>826</lpage><?supplied-pmid 28884860?><pub-id pub-id-type="pmid">28884860</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischoff</surname><given-names>D</given-names></name><name><surname>Spivakovsky</surname><given-names>S</given-names></name></person-group><article-title>Are pharmacological treatments for oro-facial pain effective?</article-title><source>Evid Based Dent.</source><year>2018</year><volume>19</volume><issue>1</issue><fpage>28</fpage><lpage>29</lpage><?supplied-pmid 29568025?><pub-id pub-id-type="pmid">29568025</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zakrzewska</surname><given-names>J</given-names></name><name><surname>Buchanan</surname><given-names>JA</given-names></name></person-group><article-title>Burning mouth syndrome</article-title><source>BMJ Clin Evid</source><year>2016</year><volume>2016</volume><fpage>1301</fpage><?supplied-pmid 26745781?><pub-id pub-id-type="pmid">26745781</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMillan</surname><given-names>R</given-names></name><name><surname>Forssell</surname><given-names>H</given-names></name><name><surname>Buchanan</surname><given-names>JA</given-names></name><name><surname>Glenny</surname><given-names>AM</given-names></name><name><surname>Weldon</surname><given-names>JC</given-names></name><name><surname>Zakrzewska</surname><given-names>JM</given-names></name></person-group><article-title>Interventions for treating burning mouth syndrome</article-title><source>Cochrane Database Syst Rev</source><year>2016</year><volume>11</volume><fpage>CD002779</fpage><?supplied-pmid 27855478?><pub-id pub-id-type="pmid">27855478</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischoff</surname><given-names>DK</given-names></name><name><surname>Spivakovsky</surname><given-names>S</given-names></name></person-group><article-title>Little evidence to support or refute interventions for the management of burning mouth syndrome</article-title><source>Evid Based Dent.</source><year>2017</year><volume>18</volume><issue>2</issue><fpage>57</fpage><lpage>58</lpage><?supplied-pmid 28642559?><pub-id pub-id-type="pmid">28642559</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>D</given-names></name></person-group><article-title>Too many reviews too few trials</article-title><source>Evid Based Dent</source><year>2018</year><volume>19</volume><issue>1</issue><fpage>2</fpage><?supplied-pmid 29568016?><pub-id pub-id-type="pmid">29568016</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toye</surname><given-names>F</given-names></name></person-group><article-title>Not everything that can be counted counts and not everything that counts can be counted' (attributed to Albert Einstein)</article-title><source>Br J Pain</source><year>2015</year><volume>9</volume><issue>1</issue><fpage>7</fpage><?supplied-pmid 26516551?><pub-id pub-id-type="pmid">26516551</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geisser</surname><given-names>ME</given-names></name><name><surname>Kratz</surname><given-names>AL</given-names></name></person-group><article-title>How condition-specific do measures of pain intensity need to be?</article-title><source>Pain</source><year>2018</year><volume>159</volume><issue>6</issue><fpage>1001</fpage><lpage>1002</lpage><?supplied-pmid 29578949?><pub-id pub-id-type="pmid">29578949</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finniss</surname><given-names>DG</given-names></name><name><surname>Kaptchuk</surname><given-names>TJ</given-names></name><name><surname>Miller</surname><given-names>F</given-names></name><name><surname>Benedetti</surname><given-names>F</given-names></name></person-group><article-title>Biological, clinical, and ethical advances of placebo effects</article-title><source>Lancet</source><year>2010</year><volume>375</volume><issue>9715</issue><fpage>686</fpage><lpage>695</lpage><?supplied-pmid 20171404?><pub-id pub-id-type="pmid">20171404</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peci&#x000f1;a</surname><given-names>M</given-names></name><name><surname>Bohnert</surname><given-names>AS</given-names></name><name><surname>Sikora</surname><given-names>M</given-names></name><name><surname>Avery</surname><given-names>ET</given-names></name><name><surname>Langenecker</surname><given-names>SA</given-names></name><name><surname>Mickey</surname><given-names>BJ</given-names></name><name><surname>Zubieta</surname><given-names>JK</given-names></name></person-group><article-title>Association between placebo-activated neural systems and antidepressant responses: neurochemistry of placebo effects in major depression</article-title><source>JAMA Psychiatry</source><year>2015</year><volume>72</volume><issue>11</issue><fpage>1087</fpage><lpage>1094</lpage><?supplied-pmid 26421634?><pub-id pub-id-type="pmid">26421634</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Souza</surname><given-names>IF</given-names></name><name><surname>M&#x000e1;rmora</surname><given-names>BC</given-names></name><name><surname>Rados</surname><given-names>PV</given-names></name><name><surname>Visioli</surname><given-names>F</given-names></name></person-group><article-title>Treatment modalities for burning mouth syndrome: a systematic review</article-title><source>Clin Oral Investig</source><year>2018</year><volume>22</volume><issue>5</issue><fpage>1893</fpage><lpage>1905</lpage><?supplied-pmid 29696421?><pub-id pub-id-type="pmid">29696421</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="other">Toyofuku A. From psychosomatic dentistry to brain dentistry. Kokubyo Gakkai Zasshi 2007;74(3):161&#x02013;168. (Article in Japanese).</mixed-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenelon</surname><given-names>M</given-names></name><name><surname>Quinque</surname><given-names>E</given-names></name><name><surname>Arrive</surname><given-names>E</given-names></name><name><surname>Catros</surname><given-names>S</given-names></name><name><surname>Fricain</surname><given-names>JC</given-names></name></person-group><article-title>Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study</article-title><source>Int J Oral Maxillofac Surg</source><year>2017</year><volume>46</volume><issue>11</issue><fpage>1505</fpage><lpage>1511</lpage><?supplied-pmid 28473243?><pub-id pub-id-type="pmid">28473243</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>K</given-names></name><name><surname>Nagamine</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Suga</surname><given-names>T</given-names></name><name><surname>Tu</surname><given-names>TTH</given-names></name><name><surname>Sugawara</surname><given-names>S</given-names></name><name><surname>Mikuzuki</surname><given-names>L</given-names></name><name><surname>Miura</surname><given-names>A</given-names></name><name><surname>Shinohara</surname><given-names>Y</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Takenoshita</surname><given-names>M</given-names></name><name><surname>Toyofuku</surname><given-names>A</given-names></name></person-group><article-title>An increase in salivary flow with amitriptyline may indicate treatment resistance in burning mouth syndrome</article-title><source>Asia Pac Psychiatry</source><year>2018</year><volume>25</volume><fpage>e12315</fpage></element-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="other">Takeshi Watanabe, Kaoru Kawasaki, Trang T.H Tu, Takayuki Suga, Shiori Sugawara, Lou Mikuzuki, Anna Miura, Yukiko Shinohara, Tatsuya Yoshikawa, Miho Takenoshita, Akira Toyofuku, Takahiko Nagamine, The QTc shortening with amitriptyline may indicate treatment resistance in chronic nonorganic orofacial pain. <italic>Clinical Neuropsychopharmacology and Therapeutics</italic>, Released April 10, 2018, Online ISSN 1884&#x02013;8826, Print ISSN.</mixed-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyofuku</surname><given-names>A</given-names></name></person-group><article-title>Efficacy of milnacipran for glossodynia patients</article-title><source>Int J Psychiatry Clin Pract</source><year>2003</year><volume>7</volume><issue>Suppl 1</issue><fpage>23</fpage><lpage>24</lpage><?supplied-pmid 24937416?><pub-id pub-id-type="pmid">24937416</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Katagiri</surname><given-names>A</given-names></name><name><surname>Umezaki</surname><given-names>Y</given-names></name><name><surname>Takenoshita</surname><given-names>M</given-names></name><name><surname>Yoshikawa</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Toyofuku</surname><given-names>A</given-names></name></person-group><article-title>Milnacipran dose-effect study in patients with burning mouth syndrome</article-title><source>Clin Neuropharmacol</source><year>2011</year><volume>34</volume><issue>4</issue><fpage>166</fpage><lpage>169</lpage><?supplied-pmid 21738023?><pub-id pub-id-type="pmid">21738023</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="other">Mitsikostas DD, Ljubisavljevic S, Deligianni CI. Refractory burning mouth syndrome: clinical and paraclinical evaluation, comorbiities. treatment and outcome <italic>J Headache Pain</italic>. 2017;18(1):40.</mixed-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagamine</surname><given-names>T</given-names></name></person-group><article-title>Responsibility of the doctor who prescribes serotonin and noradrenaline reuptake inhibitors for patients with chronic musculoskeletal pain</article-title><source>Psychiatry Clin Neurosci</source><year>2018</year><volume>72</volume><issue>1</issue><fpage>45</fpage><lpage>46</lpage><?supplied-pmid 29064131?><pub-id pub-id-type="pmid">29064131</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riediger</surname><given-names>C</given-names></name><name><surname>Schuster</surname><given-names>T</given-names></name><name><surname>Barlinn</surname><given-names>K</given-names></name><name><surname>Maier</surname><given-names>S</given-names></name><name><surname>Weitz</surname><given-names>J</given-names></name><name><surname>Siepmann</surname><given-names>T</given-names></name></person-group><article-title>Adverse effects of antidepressants for chronic pain: a systematic review and Meta-analysis</article-title><source>Front Neurol</source><year>2017</year><volume>8</volume><fpage>307</fpage><?supplied-pmid 28769859?><pub-id pub-id-type="pmid">28769859</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="other">Drossman DA, Tack J, Ford AC, Szigethy E, T&#x000f6;rnblom H, Van Oudenhove L. Neuromodulators for functional gastrointestinal disorders (disorders of gut&#x02212;brain interaction): a Rome Foundation working team report. Gastroenterology 2018;154:1140&#x02013;1171.</mixed-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takenoshita</surname><given-names>M</given-names></name><name><surname>Motomura</surname><given-names>H</given-names></name><name><surname>Toyofuku</surname><given-names>A</given-names></name></person-group><article-title>Low-dose aripiprazole augmentation in amitriptyline-resistant burning mouth syndrome: results from two cases</article-title><source>Pain Med</source><year>2017</year><volume>18</volume><issue>4</issue><fpage>814</fpage><lpage>815</lpage><?supplied-pmid 27558854?><pub-id pub-id-type="pmid">27558854</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umezaki</surname><given-names>Y</given-names></name><name><surname>Takenoshita</surname><given-names>M</given-names></name><name><surname>Toyofuku</surname><given-names>A</given-names></name></person-group><article-title>Low-dose aripiprazole for refractory burning mouth syndrome</article-title><source>Neuropsychiatr Dis Treat</source><year>2016</year><volume>12</volume><fpage>1229</fpage><lpage>1231</lpage><?supplied-pmid 27279742?><pub-id pub-id-type="pmid">27279742</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jimenez</surname><given-names>XF</given-names></name><name><surname>Sundararajan</surname><given-names>T</given-names></name><name><surname>Covington</surname><given-names>EC</given-names></name></person-group><article-title>A systematic review of atypical antipsychotics in chronic pain management: olanzapine demonstrates potential in central sensitization, fibromyalgia, and headache/migraine</article-title><source>Clin J Pain</source><year>2018</year><volume>34</volume><issue>6</issue><fpage>585</fpage><lpage>591</lpage><?supplied-pmid 29077621?><pub-id pub-id-type="pmid">29077621</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heckmann</surname><given-names>SM</given-names></name><name><surname>Kirchner</surname><given-names>E</given-names></name><name><surname>Grushka</surname><given-names>M</given-names></name><name><surname>Wichmann</surname><given-names>MG</given-names></name></person-group><article-title>Hummel T. A double-blind study on clonazepam in patients with burning mouth syndrome</article-title><source>Laryngoscope</source><year>2012</year><volume>122</volume><issue>4</issue><fpage>813</fpage><lpage>816</lpage><?supplied-pmid 22344742?><pub-id pub-id-type="pmid">22344742</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuten-Shorrer</surname><given-names>M</given-names></name><name><surname>Treister</surname><given-names>NS</given-names></name><name><surname>Stock</surname><given-names>S</given-names></name><name><surname>Kelley</surname><given-names>JM</given-names></name><name><surname>Ji</surname><given-names>YD</given-names></name><name><surname>Woo</surname><given-names>SB</given-names></name><name><surname>Lerman</surname><given-names>MA</given-names></name><name><surname>Palmason</surname><given-names>S</given-names></name><name><surname>Sonis</surname><given-names>ST</given-names></name><name><surname>Villa</surname><given-names>A</given-names></name></person-group><article-title>Topical clonazepam solution for the Management of Burning Mouth Syndrome: a retrospective Study</article-title><source>J Oral Facial Pain Headache</source><year>2017</year><volume>31</volume><issue>3</issue><fpage>257</fpage><lpage>263</lpage><?supplied-pmid 28738111?><pub-id pub-id-type="pmid">28738111</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname><given-names>CW</given-names></name><name><surname>Brett</surname><given-names>AS</given-names></name></person-group><article-title>Gabapentin and Pregabalin for pain - is increased prescribing a cause for concern?</article-title><source>N Engl J Med</source><year>2017</year><volume>377</volume><issue>5</issue><fpage>411</fpage><lpage>414</lpage><?supplied-pmid 28767350?><pub-id pub-id-type="pmid">28767350</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergdahl</surname><given-names>J</given-names></name><name><surname>Anneroth</surname><given-names>G</given-names></name><name><surname>Perris</surname><given-names>H</given-names></name></person-group><article-title>Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study</article-title><source>J Oral Pathol Med</source><year>1995</year><volume>24</volume><issue>5</issue><fpage>213</fpage><lpage>215</lpage><?supplied-pmid 7616460?><pub-id pub-id-type="pmid">7616460</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><mixed-citation publication-type="other">Femiano F, Gombos F, Scully C. Burning mouth syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid). and combination therapy <italic>Med Oral</italic>. 2004;9(1):8&#x02013;13.</mixed-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komiyama</surname><given-names>O</given-names></name><name><surname>Nishimura</surname><given-names>H</given-names></name><name><surname>Makiyama</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Group cognitive-behavioral intervention for patients with burning mouth syndrome</article-title><source>J Oral Sci</source><year>2013</year><volume>55</volume><issue>1</issue><fpage>17</fpage><lpage>22</lpage><?supplied-pmid 23485596?><pub-id pub-id-type="pmid">23485596</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wergeland</surname><given-names>GJ</given-names></name><name><surname>Fjermestad</surname><given-names>KW</given-names></name><name><surname>Marin</surname><given-names>CE</given-names></name><etal/></person-group><article-title>An effectiveness study of individual vs. group cognitive behavioral therapy for anxiety disorders in youth</article-title><source>Behav Res Ther</source><year>2014</year><volume>57</volume><fpage>1</fpage><lpage>12</lpage><?supplied-pmid 24727078?><pub-id pub-id-type="pmid">24727078</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>H</given-names></name><name><surname>Himachi</surname><given-names>M</given-names></name><name><surname>Furukawa</surname><given-names>H</given-names></name><etal/></person-group><article-title>Cognitive profile of patients with burning mouth syndrome in the Japanese population</article-title><source>Odontology</source><year>2010</year><volume>98</volume><issue>2</issue><fpage>160</fpage><lpage>164</lpage><?supplied-pmid 20652795?><pub-id pub-id-type="pmid">20652795</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>H</given-names></name><name><surname>Chiba</surname><given-names>I</given-names></name><name><surname>Sakano</surname><given-names>Y</given-names></name><name><surname>Toyofuku</surname><given-names>A</given-names></name><name><surname>Abiko</surname><given-names>Y</given-names></name></person-group><article-title>Cognitive behavioral therapy for psychosomatic problems in dental settings</article-title><source>Biopsychosoc Med.</source><year>2017</year><volume>13</volume><issue>11</issue><fpage>18</fpage></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brailo</surname><given-names>V</given-names></name><name><surname>Firi&#x00107;</surname><given-names>M</given-names></name><name><surname>Vu&#x0010d;i&#x00107;evi&#x00107; Boras</surname><given-names>V</given-names></name><name><surname>Andabak Rogulj</surname><given-names>A</given-names></name><name><surname>Krstevski</surname><given-names>I</given-names></name><name><surname>Alajbeg</surname><given-names>I</given-names></name></person-group><article-title>Impact of reassurance on pain perception in patients with primary burning mouth syndrome</article-title><source>Oral Dis</source><year>2016</year><volume>22</volume><issue>6</issue><fpage>512</fpage><lpage>516</lpage><?supplied-pmid 27101802?><pub-id pub-id-type="pmid">27101802</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Jornet</surname><given-names>P</given-names></name><name><surname>Lucero-Berdugo</surname><given-names>M</given-names></name><name><surname>Castillo-Felipe</surname><given-names>C</given-names></name><name><surname>Zamora Lavella</surname><given-names>C</given-names></name><name><surname>Ferrandez-Pujante</surname><given-names>A</given-names></name><name><surname>Pons-Fuster</surname><given-names>A</given-names></name></person-group><article-title>Assessment of self-reported sleep disturbance and psychological status in patients with burning mouth syndrome</article-title><source>J Eur Acad Dermatol Venereol</source><year>2015</year><volume>29</volume><issue>7</issue><fpage>1285</fpage><lpage>1290</lpage><?supplied-pmid 25351854?><pub-id pub-id-type="pmid">25351854</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheatle</surname><given-names>MD</given-names></name><name><surname>Foster</surname><given-names>S</given-names></name><name><surname>Pinkett</surname><given-names>A</given-names></name><name><surname>Lesneski</surname><given-names>M</given-names></name><name><surname>Qu</surname><given-names>D</given-names></name><name><surname>Dhingra</surname><given-names>L</given-names></name></person-group><article-title>Assessing and managing sleep disturbance in patients with chronic pain</article-title><source>Sleep Med Clin</source><year>2016</year><volume>11</volume><issue>4</issue><fpage>531</fpage><lpage>541</lpage><?supplied-pmid 28118876?><pub-id pub-id-type="pmid">28118876</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lami</surname><given-names>MJ</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>MP</given-names></name><name><surname>Mir&#x000f3;</surname><given-names>E</given-names></name><etal/></person-group><article-title>Efficacy of combined cognitive- behavioral therapy for insomnia and pain in patients with fibromyalgia: a randomized controlled trial</article-title><source>Cogn Ther Res</source><year>2018</year><volume>42</volume><issue>1</issue><fpage>63</fpage><lpage>79</lpage></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulloch</surname><given-names>AG</given-names></name><name><surname>Patten</surname><given-names>SB</given-names></name></person-group><article-title>Non-adherence with psychotropic medications in the general population</article-title><source>Soc Psychiatry Psychiatr Epidemiol</source><year>2010</year><volume>45</volume><issue>1</issue><fpage>47</fpage><lpage>56</lpage><?supplied-pmid 19347238?><pub-id pub-id-type="pmid">19347238</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname><given-names>Y</given-names></name><name><surname>Hata</surname><given-names>H</given-names></name><name><surname>Kitamori</surname><given-names>S</given-names></name><name><surname>Onodera</surname><given-names>M</given-names></name><name><surname>Kitagawa</surname><given-names>Y</given-names></name></person-group><article-title>An open-label, noncomparative, dose escalation pilot study of the effect of paroxetine in treatment of burning mouth syndrome</article-title><source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source><year>2009</year><volume>107</volume><issue>1</issue><fpage>e6</fpage><lpage>11</lpage><?supplied-pmid 18996028?><pub-id pub-id-type="pmid">18996028</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palacio</surname><given-names>A</given-names></name><name><surname>Garay</surname><given-names>D</given-names></name><name><surname>Langer</surname><given-names>B</given-names></name><name><surname>Taylor</surname><given-names>J</given-names></name><name><surname>Wood</surname><given-names>BA</given-names></name><name><surname>Tamariz</surname><given-names>L</given-names></name></person-group><article-title>Motivational interviewing improves medication adherence: a systematic review and Meta- analysis</article-title><source>J Gen Intern Med</source><year>2016</year><volume>31</volume><issue>8</issue><fpage>929</fpage><lpage>940</lpage><?supplied-pmid 27160414?><pub-id pub-id-type="pmid">27160414</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umezaki</surname><given-names>Y</given-names></name><name><surname>Badran</surname><given-names>BW</given-names></name><name><surname>DeVries</surname><given-names>WH</given-names></name><name><surname>Moss</surname><given-names>J</given-names></name><name><surname>Gonzales</surname><given-names>T</given-names></name><name><surname>George</surname><given-names>MS</given-names></name></person-group><article-title>The efficacy of daily prefrontal repetitive transcranial magnetic stimulation (rTMS) for burning mouth syndrome (BMS): a randomized controlled single-blind Study</article-title><source>Brain Stimul</source><year>2016</year><volume>9</volume><issue>2</issue><fpage>234</fpage><lpage>242</lpage><?supplied-pmid 26597930?><pub-id pub-id-type="pmid">26597930</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umezaki</surname><given-names>Y</given-names></name><name><surname>Badran</surname><given-names>BW</given-names></name><name><surname>Gonzales</surname><given-names>TS</given-names></name><name><surname>George</surname><given-names>MS</given-names></name></person-group><article-title>Daily left prefrontal repetitive transcranial magnetic stimulation for medication-resistant burning mouth syndrome</article-title><source>Int J Oral Maxillofac Surg</source><year>2015</year><volume>44</volume><issue>8</issue><fpage>1048</fpage><lpage>1051</lpage><?supplied-pmid 25979192?><pub-id pub-id-type="pmid">25979192</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suda</surname><given-names>S</given-names></name><name><surname>Takagai</surname><given-names>S</given-names></name><name><surname>Inoshima-Takahashi</surname><given-names>K</given-names></name><name><surname>Sugihara</surname><given-names>G</given-names></name><name><surname>Mori</surname><given-names>N</given-names></name><name><surname>Takei</surname><given-names>N</given-names></name></person-group><article-title>Electroconvulsive therapy for burning mouth syndrome</article-title><source>Acta Psychiatr Scand</source><year>2008</year><volume>118</volume><issue>6</issue><fpage>503</fpage><lpage>504</lpage><?supplied-pmid 18764838?><pub-id pub-id-type="pmid">18764838</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGirr</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>L</given-names></name><name><surname>Vila-Rodriguez</surname><given-names>F</given-names></name></person-group><article-title>Idiopathic burning mouth syndrome: a common treatment-refractory somatoform condition responsive to ECT</article-title><source>Psychiatry Res</source><year>2014</year><volume>216</volume><issue>1</issue><fpage>158</fpage><lpage>159</lpage><?supplied-pmid 24560021?><pub-id pub-id-type="pmid">24560021</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>BY</given-names></name><name><surname>Tang</surname><given-names>HD</given-names></name><name><surname>Qiao</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>SD</given-names></name></person-group><article-title>Mental training for cognitive improvement in elderly people: what have we learned from clinical and neurophysiologic studies?</article-title><source>Curr Alzheimer Res</source><year>2015</year><volume>12</volume><issue>6</issue><fpage>543</fpage><lpage>552</lpage><?supplied-pmid 26238812?><pub-id pub-id-type="pmid">26238812</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeBlanc</surname><given-names>A</given-names></name><name><surname>Herrin</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>MD</given-names></name><name><surname>Inselman</surname><given-names>JW</given-names></name><name><surname>Branda</surname><given-names>ME</given-names></name><name><surname>Shah</surname><given-names>ND</given-names></name><name><surname>Heim</surname><given-names>EM</given-names></name><name><surname>Dick</surname><given-names>SR</given-names></name><name><surname>Linzer</surname><given-names>M</given-names></name><name><surname>Boehm</surname><given-names>DH</given-names></name><name><surname>Dall-Winther</surname><given-names>KM</given-names></name><name><surname>Matthews</surname><given-names>MR</given-names></name><name><surname>Yost</surname><given-names>KJ</given-names></name><name><surname>Shepel</surname><given-names>KK</given-names></name><name><surname>Montori</surname><given-names>VM</given-names></name></person-group><article-title>Shared decision making for antidepressants in primary care: a cluster randomized trial</article-title><source>JAMA Intern Med</source><year>2015</year><volume>175</volume><issue>11</issue><fpage>1761</fpage><lpage>1770</lpage><?supplied-pmid 26414670?><pub-id pub-id-type="pmid">26414670</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Damme</surname><given-names>S</given-names></name><name><surname>Becker</surname><given-names>S</given-names></name><name><surname>Van Der Linden</surname><given-names>D</given-names></name></person-group><article-title>Tired of pain? Toward a better understanding of fatigue in chronic pain</article-title><source>Pain</source><year>2018</year><volume>159</volume><fpage>7</fpage><lpage>10</lpage><?supplied-pmid 28891867?><pub-id pub-id-type="pmid">28891867</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solberg</surname><given-names>LI</given-names></name><name><surname>Crain</surname><given-names>AL</given-names></name><name><surname>Rubenstein</surname><given-names>L</given-names></name><name><surname>Un&#x000fc;tzer</surname><given-names>J</given-names></name><name><surname>Whitebird</surname><given-names>RR</given-names></name><name><surname>Beck</surname><given-names>A</given-names></name></person-group><article-title>How much shared decision making occurs in usual primary care of depression?</article-title><source>J Am Board Fam Med</source><year>2014</year><volume>27</volume><issue>2</issue><fpage>199</fpage><lpage>208</lpage><?supplied-pmid 24610182?><pub-id pub-id-type="pmid">24610182</pub-id></element-citation></ref></ref-list></back></article>